Choose test
Where to pass the test?
Test from the National Health Service
Loyalty program
Nurse visit
For clients
  • Screening 40+
  • Wallet
  • Special offers
  • Partner offers
  • Preparing a child for tests
  • Doctors’ consultations
  • Cytological passport
  • FAQ
  • “Be Healthy” portal
Laboratory
  • News
  • About us
  • Equipment
  • Licenses and certificates
  • Leadership
  • Career
  • Contacts
For doctor
  • Information for doctors
Business
  • Tissue diagnostics
  • Cooperation with Synevo
  • Business Cabinet
  1. Home
  2. Tests sections
  3. 2090. Tumor marker GI (CA 242)

All test sections

Choose the category you’re interested in

TOP tests

What to check

Heart and blood vesselsSugar and metabolismThyroid glandImmunityInfectionsWomen's and men's healthTumor markersLiver and kidneysVitamins and trace elementsAllergensBlood type and Rh factorGenetic testsSkin, Hair, and Nails

Diseases

Cardiovascular diseasesDiabetes mellitus and metabolismThyroid gland and hormonal disordersInfectious diseasesAnemia and blood diseasesAllergies and immunological conditionsUrogenital infections and STDsTORCH infectionsPathology of pregnancyOncology and tumor screeningObesity and endocrine disordersHepatitis and liver diseasesGastroenterology and the gastrointestinal tractInflammatory and rheumatic diseasesRenal failure and kidney diseasesNeurological disordersTuberculosisWorms and parasitic infestationsGenetic diseases and mutation carriageCeliac disease and food intoleranceHealth of skin, hair and nails

For whom

For womenFor menFor childrenFor the elderlyWhen planning a pregnancy For pregnant womenBefore surgeryFor athletes and active peopleFor beautyFor vegetarians and vegans

Check-up

Women'sMen'sChildren'sFor the elderlyCardiovascularHormonalMetabolism and diabetesSkin, Hair and Nail HealthImmune and InfectiousOncologyVitamins and MineralsReproductive HealthAnnual PreventiveSpecializedAdvanced

Panels

General clinicalThyroid panelPhosphorus-calcium metabolismReproductive panelHypothalamic-pituitary-adrenal axisCarbohydrate metabolismPrenatal diagnosticsKaryotypingOncology panelOther infectionsHepatitisTorch infectionsUrogenital infectionsCoronavirus SARS-CoV-2Parasitic infectionsHivLyme disease (borreliosis)Helicobacter pyloriTuberculosisAutoimmunological panelImmunological causes of infertilityCeliac diseaseRheumatological panelGeneral immunologyAntiphospholipid syndromeBacteriological panelCytological panelPathomorphological panelBiochemical panelVitaminsAnemiaCardiovascular disease markersAcute phase markersTherapeutic drug monitoringHeavy metalsAmino acids. Organic acidsGenetic panelScreening packagesAllergological panel

Biomaterial

Blood ScrapingUrineFeces Sperm SalivaProstate secretSmear / Bacterial culturePlacenta / amniotic fluidBile / breast milkLiquorPathomorphologyCytology on glass

2090. Tumor marker GI (CA 242)

2090. Tumor marker GI (CA 242)

Turnaround time (days): 1

740 ₴

Description

The gastrointestinal tumor marker (CA 242) is a specific tumor marker for tumors of the gastrointestinal tract (stomach, colon, rectum, and pancreas). It is used for diagnosis, treatment monitoring, and recurrence and metastasis monitoring. Recommended in combination with the CA 19-9, CA 50, and CA 72-4 markers.

The CA 242 tumor marker is a carbohydrate antigen produced by epithelial cells of the gastrointestinal tract. Elevated levels in the blood may indicate malignant neoplasms of the pancreas, colon, or rectum.

A distinctive feature of the CA 242 marker is its high specificity for malignant processes – it rarely increases in benign conditions (pancreatitis, hepatitis, peptic ulcers), making it valuable for the differential diagnosis between benign and malignant gastrointestinal lesions.

CA 242 is primarily used in combination with other markers (CA 19-9, CA 50, REA, CA 72-4) to improve diagnostic accuracy. Elevated CA 242 levels require a comprehensive approach to interpretation, taking into account clinical data, instrumental and laboratory test results.

When and who needs the test?

  • patients with suspected tumors of the stomach, pancreas, colon, or rectum;
  • to assess the effectiveness of treatment for gastrointestinal oncology;
  • to monitor recurrences and metastases in patients diagnosed with cancer;
  • to distinguish benign gastrointestinal lesions (e.g., pancreatitis, chronic liver disease) from malignant tumors.

Biological material

  • Venous blood

Preparing for a blood test

In order to exclude factors that may affect the test results, we recommend to follow the preparation rules:

  • an important condition for laboratory tests is to take blood on an empty stomach.
  • 6-12 hours before the test, you should avoid eating, drinking alcohol, smoking, and limit physical activity. Drinking...

2090. Tumor marker GI (CA 242)

740 ₴

Information service

0 800 60 55 00

Free from mobile and stationary operators in Ukraine (except for the temporarily occupied territories)

Our social media

Media inquiries contacts

press@synevo.ua

About Us

About us
Career
News
Contacts

Customers

Choose test
Where to pass the test?
Get results
Special offers
“Be Healthy” portal

Legal information

Public contract
Loyalty program rules
Financial statements
Licenses and certificates
Tender
Legal conditions of special offers
Providing services to minors
Synevo, 2026